CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions Source: Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay,... Read more
